Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Streptococcus thermophilus

From Wikipedia, the free encyclopedia
Species of bacterium

Streptococcus thermophilus
Scientific classificationEdit this classification
Domain:Bacteria
Kingdom:Bacillati
Phylum:Bacillota
Class:Bacilli
Order:Lactobacillales
Family:Streptococcaceae
Genus:Streptococcus
Species:
S. thermophilus
Binomial name
Streptococcus thermophilus
Orla-Jensen 1919
(Approved Lists 1980)[1][a]
Synonyms

Streptococcus salivarius subsp.thermophilus (Orla-Jensen, 1919) Farrow et Collins 1984

Streptococcus thermophilus formerly known asStreptococcus salivariussubsp. thermophilus[4][2] is agram-positive bacterium, and afermentativefacultative anaerobe, of theviridans group.[5] It tests negative forcytochrome,oxidase, andcatalase, and positive foralpha-hemolytic activity.[5] It isnon-motile and does not formendospores.[5]S. thermophilus isfimbriated.[6]

It is also classified as alactic acid bacterium.[7]S. thermophilus is found in fermented milk products and is generally used in the production ofyogurt,[8] alongsideLactobacillus delbrueckii subsp.bulgaricus. The two species are synergistic, andS. thermophilus probably providesL. d. bulgaricus withfolic acid andformic acid, which it uses forpurine synthesis.[9]S. thermophilus has an optimal growth temperature range of 35–42 °C (95–108 °F), whileL. d. bulgaricus has an optimal range of 43–46 °C (109–115 °F).[10]

Classification

[edit]

At least 26 strains ofS. thermophilus have been identified and had their genomes sequenced.[11]

Test typeTestCharacteristics
Colony charactersColorYellowish
ShapeConvex
TypeRound
Morphological charactersShapeRound
Size0.7-0.9 μm
Physiological charactersMotility-
Biological charactersGram stain+
Catalase-
Oxidase-
Cytochrome-

Uses

[edit]

S. thermophilus is one of the most widely used bacteria in the dairy industry. USDA statistics from 1998 showed that more than 1.02 billion kilograms ofmozzarella cheese and 621 million kilograms of yogurt were produced fromS. thermophilus.[12] Although its genus,Streptococcus, includes some pathogenic species, food industries considerS. thermophilus a safer bacterium than many otherStreptococcus species. In fact, yogurt and cheese that contain live cultures ofS. thermophilus are thought to be beneficial to health.[13][better source needed] Live cultures ofS. thermophilus make it easier for people who arelactose-intolerant to digest dairy products. The bacteria breaks downlactose, the sugar in milk, that lactose-intolerant people find difficult to digest.[14]

Yogurt production

[edit]

As early as the 1900s,S. thermophilus was used to makeyogurt. Its purpose is to turn lactose, the sugar in milk, into lactic acid. The increase in lactic acid turns milk into the gel-like structure characteristic of yogurt.[15]

Nomenclature

[edit]

"Streptococcus" derives from a Greek term meaning "twisted kernel" and refers to the way the bacterium is grouped in chains that resemble a string of beads.[16] "Thermophilus" derives from the Greekthermē, meaning "heat", andphilus, meaning to appreciate or to like. It refers to an organism's ability to thrive at high temperatures.[17]

Research

[edit]

Pathogenic potential

[edit]

The genusStreptococcus includes several pathogenic species, such asS. pneumoniae andS. pyogenes, but food industries considerS. thermophilus non-pathogenic.S. thermophilus is believed to have developed separately from pathogenicStreptococcus species for at least 3000 years. Research teams have sequenced the genome of two strains ofS. thermophilus, CNRZ1066 and LMG13811, and stated that the bacteria are not dangerous.[18]

Adjuvant

[edit]

S. thermophilus strain Orla-Jensen 1919[19] is a constituent inVSL#3. This standardized formulation of live bacteria may be used in combination with conventional therapies to treatulcerative colitis.[20][21] The use of theS. thermophilus-containing VSL#3 may reduce inflammation in mice.[22]

Reduced-fat cheese

[edit]

S. thermophilus helps make reduced-fat cheese with similar characteristics to regular, full-fat cheese. In the experiment, two different strains of bacteria are used to make reduced-fat cheddar cheese: a strain ofLactococcus lactis and a strain ofS. thermophilus. These bacteria are chosen because they produceexopolysaccharide (EPS), which give reduced-fat cheese a texture and flavor like that of regular cheese.[citation needed]

L. lactis produces cheese with higher moisture levels compared to other reduced-fat cheeses;S. thermophilus produces cheese with a lower moisture content and a less bitter taste. It was concluded that applying bothL. lactis andS. thermophilus strains would create higher-quality reduced-fat cheese with characteristics like those of regular cheese.[23]

Cancer

[edit]

Chemotherapy often causesmucositis, severeinflammation of primarily thesmall intestines. Currently, there is no treatment to alleviate the symptoms of mucositis caused by chemotherapy. Whenrats were inflicted with mucositis by chemotherapy drugs, the intestinal tissues in those pretreated withStreptococcus thermophilus TH-4 functioned more healthily and were less distressed.[24]

Antibiotic-associated diarrhea

[edit]

Strains ofS. thermophilus have also reduced risks ofantibiotic-associated diarrhea (AAD), an issue that results from taking antibiotics. Antibiotics can have the adverse effect of destroying beneficial bacteria and causing harmful bacteria to multiply, which invokes AAD. Adults who ate yogurt containingS. thermophilus while being treated with antibiotics had lower rates of AAD than the control group (12.4% vs. 23.7%).[25]

Longevity in other organisms

[edit]

Streptococcus thermophilus has been linked to longevity in some living organisms. In an experiment performed on the bacteriophagous nematode speciesCaenorhabditis elegans, consumption ofS. thermophilus was shown to cause significant longevity when compared to specimens that consumedE. coli OP50, a strain used as a standard food source. Additionally, there was no significant deviation in growth rate or brood size, indicating that it wasn't caused by caloric restriction. Instead, its life-extending effects were linked to increased expression of the genedaf-16. This effect further enhances the expression of other antioxidant genes, thereby slowing down the aging process.[26]

Health concerns

[edit]

Althoughprobiotics, in general, are considered safe, there are concerns about their use in certain cases.[27][28] Some people, such as those withcompromised immune systems,short bowel syndrome,central venous catheters,heart valve disease andpremature infants, may be at higher risk for adverse events.[29] Rarely, the use ofprobiotics has causedsepsis in children with lowered immune systems or in those who are already critically ill.[30]

References

[edit]
  1. ^The name appears both on Approved Lists 1980 and on Validation List No. 54 of 1995.[2] When cited as the latter, the author string would be "(ex Orla-Jensen 1919) Schleifer et al. 1995". However, the validation of a name already on the Approved Lists is an obvious error and the older citation should take precedence.[1] Nevertheless, Schleifer's 1991 "revival" article dos provide additional evidence for the species's distinctiveness.[3]
  1. ^abspecies/streptococcus-thermophilus entry inLPSN;Parte, Aidan C.; Sardà Carbasse, Joaquim; Meier-Kolthoff, Jan P.; Reimer, Lorenz C.; Göker, Markus (1 November 2020)."List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ".International Journal of Systematic and Evolutionary Microbiology.70 (11):5607–5612.doi:10.1099/ijsem.0.004332.
  2. ^ab"Validation of the Publication of New Names and New Combinations Previously Effectively Published Outside the IJSB: List No. 54".International Journal of Systematic Bacteriology.45 (3):619–620. July 1995.doi:10.1099/00207713-45-3-619.
  3. ^Schleifer, Karl Heinz; Ehrmann, Mathias; Krusch, Uli; Neve, Horst (October 1991). "Revival of the Species Streptococcus thermophilus (ex Orla-Jensen, 1919) nom. rev".Systematic and Applied Microbiology.14 (4):386–388.doi:10.1016/S0723-2020(11)80314-0.
  4. ^Tannock, Gerald W., ed. (2005).Probiotics And Prebiotics: Scientific Aspects. Caister Academic Press. p. 43.ISBN 978-1-904455-01-1. Retrieved31 March 2014.
  5. ^abc"Bacteria Genomes –Streptococcus Thermophilus". European Bioinformatics Institute. Archived fromthe original on 19 February 2013.
  6. ^"Streptococcus_salivarius".
  7. ^Courtin, P.; Rul, F. O. (2003)."Interactions between microorganisms in a simple ecosystem: yogurt bacteria as a study model".Le Lait.84 (1–2):125–134.doi:10.1051/lait:2003031.
  8. ^Kiliç, A. O.; Pavlova, S. I.; Ma, W. G.; Tao, L. (1996)."Analysis of Lactobacillus phages and bacteriocins in American dairy products and characterization of a phage isolated from yogurt".Applied and Environmental Microbiology.62 (6):2111–6.Bibcode:1996ApEnM..62.2111K.doi:10.1128/AEM.62.6.2111-2116.1996.PMC 167989.PMID 8787408.
  9. ^Sieuwerts, S.; Molenaar, D.; Van Hijum, S. A. F. T.; Beerthuyzen, M.; Stevens, M. J. A.; Janssen, P. W. M.; Ingham, C. J.; De Bok, F. A. M.; De Vos, W. M.; Van Hylckama Vlieg, J. E. T. (2010)."Mixed-Culture Transcriptome Analysis Reveals the Molecular Basis of Mixed-Culture Growth inStreptococcus thermophilus andLactobacillus bulgaricus".Applied and Environmental Microbiology.76 (23):7775–7784.Bibcode:2010ApEnM..76.7775S.doi:10.1128/AEM.01122-10.PMC 2988612.PMID 20889781.
  10. ^Lyn C. Radke-Mitchel; W. E. Sandine (1986)."Influence of Temperature on Associative Growth ofStreptococcus therrnophilus andLactobacillus bulgaricus".J. Dairy Sci.69 (10):2558–2568.doi:10.3168/jds.S0022-0302(86)80701-9.PMID 3805441.
  11. ^"Contributing Species, Genome:Streptococcus thermophilus LMD-9, Clique ID: 480". The Integrated Microbial Genomes, The US Department of Energy Office of Science, Lawrence Berkeley National Laboratory and The Regents of the University of California. Retrieved25 June 2016.
  12. ^Hutkins, Robert (2002). "Streptococcus Thermophilus LMD-9".JGI Microbes.
  13. ^Taylor, John R. and Mitchell, Deborah.The Wonder of Probiotics. New York, NY: St. Martin's Press, 2007.
  14. ^Leboffe, Michael (1 January 2012).Microbiology: Laboratory Theory and Application. Morton Publishing Company. p. 33.ISBN 978-1-61731-028-7.
  15. ^Delcour, J.; Ferain, T.; Hols, P. (2000). "Advances in the Genetics of Thermophilic Lactic Acid Bacteria".Food Biotechnology.11 (5):497–504.doi:10.1016/s0958-1669(00)00134-8.PMID 11024370.
  16. ^"Streptococcus."Encyclopædia Britannica.Encyclopædia Britannica Online. 13 April 2011.
  17. ^"Thermophile."Encyclopædia Britannica.Encyclopædia Britannica Online, 2011. 24 April 2011.
  18. ^"Streptococcus Thermophilus: A Bacterium Which Is Harmless to Health". International Research Associates. 14 November 2006. Web. 25 April 2011.
  19. ^Hood, Kerenza; Nuttall, Jacqui; Gillespie, David; Shepherd, Victoria; Wood, Fiona; Duncan, Donna; Stanton, Helen; Espinasse, Aude; Wootton, Mandy; Acharjya, Aruna; Allen, Stephen; Bayer, Antony; Carter, Ben; Cohen, David; Francis, Nick; Howe, Robin; Mantzourani, Efi; Thomas-Jones, Emma; Toghill, Alun; Butler, Christopher C. (2014)."Probiotics for Antibiotic-Associated Diarrhoea (PAAD): a prospective observational study of antibiotic-associated diarrhoea (includingClostridioides difficile-associated diarrhoea) in care homes".Health Technology Assessment.18 (63):1–84.doi:10.3310/hta18630.ISSN 1366-5278.PMC 4781053.PMID 25331573.
  20. ^Ghouri, Yezaz A.; Richards, David M.; Rahimi, Erik F.; Krill, Joseph T.; Jelinek, Katherine A.; DuPont, Andrew W. (9 December 2014)."Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease".Clinical and Experimental Gastroenterology.7:473–487.doi:10.2147/CEG.S27530.PMC 4266241.PMID 25525379.
  21. ^Mardini, Houssam E.; Grigorian, Alla Y. (2014)."Probiotic Mix VSL#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis".Inflammatory Bowel Diseases.20 (9):1562–1567.doi:10.1097/MIB.0000000000000084.ISSN 1078-0998.PMID 24918321.S2CID 36218602; Access provided by theUniversity of Pittsburgh{{cite journal}}: CS1 maint: postscript (link)
  22. ^"The probiotic mixture VSL#3 has differential effects on intestinal immune parameters in healthy female BALB/c and C57BL/". National Center for Biotechnology Information, National Institutes of Health. 23 October 2014. Retrieved24 May 2016.
  23. ^Awad, S.; Hassan, A. N.; Muthukumarappan, K. (2005)."Application of Exopolysaccharide-Producing Cultures in Reduced-Fat Cheddar Cheese".Journal of Dairy Science.88 (12):4204–4213.doi:10.3168/jds.s0022-0302(05)73106-4.PMID 16291611.
  24. ^Whitford, E. J.; Cummins, A. G.; Butler, R. N.; Prisciandaro, L. D.; Fauser, J. K.; Yazbeck, R; Lawrence, A; Cheah, K. Y.; Wright, T. H.; Lymn, K. A.; Howarth, G. S. (2009)."Effects ofStreptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent, 5-Fluorouracil (5-FU)".Cancer Biology & Therapy.8 (6):505–11.doi:10.4161/cbt.8.6.7594.PMID 19305160.
  25. ^Ripudaman S. Beniwal; Vincent C. Arena; Leno Thomas; Sudhir Narla; Thomas F. Imperiale; Rauf A. Chaudhry; Usman A. Ahmad (2003). "A Randomized Trial of Yogurt for Prevention of Antibiotic-Associated Diarrhea".Digestive Diseases and Sciences.48 (10):2077–2082.doi:10.1023/A:1026155328638.PMID 14627358.S2CID 23021761.
  26. ^Desaka, Natsumi; Ota, Chinatsu; Nishikawa, Hitomi; Yasuda, Kayo; Ishii, Naoaki; Bito, Tomohiro; Kishinaga, Yukio; Naito, Yuji; Higashimura, Yasuki (January 2022)."Streptococcus thermophilus extends lifespan through activation of DAF-16-mediated antioxidant pathway inCaenorhabditis elegans".Journal of Clinical Biochemistry and Nutrition.70 (1):7–13.doi:10.3164/jcbn.21-56.ISSN 0912-0009.PMC 8764109.PMID 35068675.
  27. ^Durchschein F.; Petritsch W.; Hammer H. F. (2016)."Diet therapy for inflammatory bowel diseases: The established and the new".World Journal of Gastroenterology (Review).22 (7):2179–94.doi:10.3748/wjg.v22.i7.2179.PMC 4734995.PMID 26900283.
  28. ^Boyle, R. J.; Robins-Browne, R. M.;Tang, M. L. (2006)."Probiotic use in clinical practice: what are the risks?".American Journal of Clinical Nutrition (Review).83 (6):1256–1264, quiz 1446–1447.doi:10.1093/ajcn/83.6.1256.PMID 16762934.
  29. ^Doron S.; Snydman D. R. (2015)."Risk and safety of probiotics".Clinical Infectious Diseases (Review).60 (Suppl 2):S129–S134.doi:10.1093/cid/civ085.PMC 4490230.PMID 25922398.
  30. ^Singhi S. C.; Kumar S. (2016)."Probiotics in critically ill children".F1000Research (Review).5: 407.doi:10.12688/f1000research.7630.1.PMC 4813632.PMID 27081478.
Varieties
Cultures
Dishes
Drinks
Related
Portal:
Streptococcus thermophilus
Authority control databases: NationalEdit this at Wikidata
Retrieved from "https://en.wikipedia.org/w/index.php?title=Streptococcus_thermophilus&oldid=1336564002"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp